Cite
Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice.
MLA
Liu, H. S., et al. “Phosphoinositide 3-Kinase Inhibitor LY294002 Ameliorates the Severity of Myosin-Induced Myocarditis in Mice.” Current Research in Translational Medicine, vol. 64, no. 1, Jan. 2016, pp. 21–27. EBSCOhost, https://doi.org/10.1016/j.retram.2016.01.012.
APA
Liu, H. S., Zhang, J., Guo, J.-L., Lin, C. Y., & Wang, Z.-W. (2016). Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice. Current Research in Translational Medicine, 64(1), 21–27. https://doi.org/10.1016/j.retram.2016.01.012
Chicago
Liu, H.S., J. Zhang, J.-L. Guo, C.Y. Lin, and Z.-W. Wang. 2016. “Phosphoinositide 3-Kinase Inhibitor LY294002 Ameliorates the Severity of Myosin-Induced Myocarditis in Mice.” Current Research in Translational Medicine 64 (1): 21–27. doi:10.1016/j.retram.2016.01.012.